Related Experiment Video
Updated: Jun 15, 2026

High-throughput Flow Cytometry Cell-based Assay to Detect Antibodies to N-Methyl-D-aspartate Receptor or Dopamine-2 Receptor in Human Serum
Published on: November 23, 2013
Anti-glutamate receptor antibodies in pediatric enteroviral encephalitis
Hisashi Kawashima1, Kazunori Suzuki, Gaku Yamanaka
1Department of Peadiatrics, Tokyo Medical University, Shinjuku-ku, Tokyo, Japan. hisashi@tokyo-med.ac.jp
Insights
Enteroviral encephalitis sequelae are linked to the immune response, not just viral load or inflammation. Targeting immunological factors may reduce long-term effects of this pediatric neurological disease.
Area of Science:
- Neurology
- Immunology
- Pediatrics
Background:
- Enteroviral encephalitis is a serious neurological condition in children.
- Understanding disease markers is crucial for predicting outcomes and sequelae.
Purpose of the Study:
- To investigate clinical symptoms and disease markers in pediatric enteroviral encephalitis.
- To identify factors associated with the development of sequelae.
Main Methods:
- Analysis of eight pediatric patients (9 months-5 years) diagnosed between 2000-2005.
- Measurement of serum and cerebrospinal fluid (CSF) markers including glutamic oxaloacetic transaminase (GOT), IL-6, ferritin, diacron-reactive oxygen metabolites (d-ROM), and viral loads.
- Detection of anti-glutamate receptor IgMdelta2 in CSF.
Main Results:
- Elevated GOT, IL-6, and ferritin were common. High IL-6 and d-ROM in CSF were observed in 86% of cases.
- Pleocytosis and high protein in CSF were rare. No significant difference in CSF viral load was found between patients with and without sequelae.
- Anti-glutamate receptor IgMdelta2 was exclusively detected in the CSF of the patient with sequelae.
Conclusions:
- Immunological phenomena, specifically anti-glutamate receptor IgMdelta2, are more closely associated with enteroviral encephalitis sequelae than inflammatory markers or viral loads.
- Targeting the immunological response may be a potential therapeutic strategy to mitigate sequelae.
- Further research is necessary to validate these findings and develop targeted therapies.
Abstract:
In order to better understand enteroviral encephalitis we investigated the clinical symptoms and several disease markers. Between 2000 and 2005 eight patients aged between 9 months and 5 years were admitted to our hospital with one case having sequela. Glutamic oxaloacetic transaminase (GOT), serum IL-6, and ferritin were elevated in most of the cases. Their IL-6 and diacron-reactive oxygen metabolites (d-ROM) in cerebral spinal fluid (CSF) were also high (86%). However, pleocytosis and high protein levels in CSF were rarely found. In viral loads of the first CSF, there were no differences between the patient with sequela and the ones without sequela. However, anti-glutamate receptor IgMdelta2 was only detected in the CSF of the patient with sequela. These findings suggest that the immunological phenomenon is more closely related to the development of sequela related to enteroviral encephalitis than other disease markers, such as inflammatory cytokine, free radicals, and viral loads. Therefore, a specific therapy against immunological status might decrease the sequela; however, further research is necessary to confirm this.
More Related Videos
07:20A Simple Cell-based Immunofluorescence Assay to Detect Autoantibody Against the N-Methyl-D-Aspartate (NMDA) Receptor in Blood
Published on: January 9, 2018
08:20Hippocampal Neuronal Cultures to Detect and Study New Pathogenic Antibodies Involved in Autoimmune Encephalitis
Published on: June 2, 2022
Related Concept Videos
Encephalitis ll: Pathophysiology
Encephalitis l: Introduction
Antiepileptic Drugs: Glutamate Antagonists
Arboviral Encephalitis
Poliomyelitis
Enzyme-Linked Immunosorbent Assay
There are many different types of ELISAs, but they all involve an antibody molecule whose constant region binds an enzyme, leaving the variable region free to bind its specific antigen. Enzyme-substrate reaction allows the antigen to be visualized or quantified.